[DOI] [PubMed] [Google Scholar] 32.Fasiolo L.T., Manniello M.D., Tratta E., Buttini F., Rossi A., Sonvico F., Bortolotti F., Russo P., Colombo G
Metabolic abnormalities other than hyperglycemia such as obesity, dyslipidemia, and hypertension were found to be important risk factors of DPN (Fig
When exogenous growth hormone floods the system, the body recognizes elevated levels and reduces its own production
Furthermore, evidence from epilepsy models indicates that semaglutide can inhibit the activation of the NLRP3 inflammasome, a multiprotein complex responsible for producing inflammatory cytokines such as IL-1 ( 5.2 Enhanced brain metabolism and insulin sensitivity The association between Alzheimers disease (AD) and metabolic dysfunction has led to the characterization of AD as Type 3 diabetes, a condition marked by impaired insulin signaling and glucose utilization in the brain (Zhai et al., 2025)